Vaxcyte, Inc.
Clinical trials sponsored by Vaxcyte, Inc., explained in plain language.
-
New vaccine combo tested to protect older adults from pneumonia
⭐️ VACCINE ⭐️ OngoingThis study is testing a new vaccine (VAX-31) designed to protect against many strains of bacteria that cause pneumonia and other serious infections. Researchers want to see if it's safe and works well when given at the same time as the annual flu shot, compared to giving them sep…
Phase: PHASE3 • Sponsor: Vaxcyte, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 04, 2026 09:21 UTC
-
New vaccine for babies aims to broaden protection against pneumococcal disease
⭐️ VACCINE ⭐️ OngoingThis study is testing a new vaccine called VAX-31 in healthy infants to see if it is safe and how well it helps their bodies build protection against pneumococcal bacteria. About 905 infants will receive four doses of either VAX-31 or an existing vaccine (PCV20) along with their …
Phase: PHASE2 • Sponsor: Vaxcyte, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 02, 2026 15:24 UTC